Literature DB >> 19885170

Business and economics of diabetes.

David C Klonoff.   

Abstract

Entities:  

Keywords:  business; diabetes; economics; product

Year:  2008        PMID： 19885170      PMCID： PMC2769700          DOI： 10.1177/193229680800200101

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


× No keyword cloud information.
  8 in total

1.  The innovator will prevail in glucose monitoring.

Authors:  M J Green
Journal:  Med Device Technol       Date:  2006-05

Review 2.  Information and communications technology in chronic disease care: what are the implications for payment?

Authors:  Michael Cronquist Christensen; Dahlia Remler
Journal:  Med Care Res Rev       Date:  2007-04       Impact factor: 3.929

3.  Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes.

Authors:  Andrew J Palmer; Sean Dinneen; James R Gavin; Alastair Gray; William H Herman; Andrew J Karter
Journal:  Curr Med Res Opin       Date:  2006-05       Impact factor: 2.580

4.  Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective.

Authors:  Peter Lindgren; Jaana Lindström; Jaakko Tuomilehto; Matti Uusitupa; Markku Peltonen; Bengt Jönsson; Ulf de Faire; Mai-Lis Hellénius
Journal:  Int J Technol Assess Health Care       Date:  2007       Impact factor: 2.188

5.  Predicted quality-adjusted life years as a composite measure of the clinical value of diabetes risk factor control.

Authors:  Julie Schmittdiel; Sandeep Vijan; Bruce Fireman; Jennifer Elston Lafata; Nina Oestreicher; Joe V Selby
Journal:  Med Care       Date:  2007-04       Impact factor: 2.983

Review 6.  Screening for type 2 diabetes: literature review and economic modelling.

Authors:  N Waugh; G Scotland; P McNamee; M Gillett; A Brennan; E Goyder; R Williams; A John
Journal:  Health Technol Assess       Date:  2007-05       Impact factor: 4.014

7.  Economic impacts attributable to the early clinical benefit of atorvastatin therapy--a US managed care perspective.

Authors:  Robert J Straka; Muhammad Mamdani; Joep Damen; C Erik E Kuntze; Larry Z Liu; Marc F Botteman; Michael J Koren
Journal:  Curr Med Res Opin       Date:  2007-07       Impact factor: 2.580

8.  Impact of a pay-for-performance incentive on support for smoking cessation and on smoking prevalence among people with diabetes.

Authors:  Christopher Millett; Jeremy Gray; Sonia Saxena; Gopalakrishnan Netuveli; Azeem Majeed
Journal:  CMAJ       Date:  2007-06-05       Impact factor: 8.262
  8 in total
  1 in total

1.  Glucose monitoring in acute care: technologies on the horizon.

Authors:  Marc C Torjman; Niti Dalal; Michael E Goldberg
Journal:  J Diabetes Sci Technol       Date:  2008-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.